Table 1 Basic information of control subjects and ACS patients
|  | Control (n = 552) | ACS (n = 619) | P value |
|---|---|---|---|
Age, y | 56.67 ± 10.87 | 58.45 ± 10.96 | 0.006 |
Male, n (%) | 272 (49.3) | 340 (54.9) | 0.053 |
Smoking, n (%) | 170(30.8) | 225(36.3) | 0.045 |
Drinking, n (%) | 112(20.3) | 123(19.9) | 0.858 |
Hypertension, n (%) | 270(48.9) | 342(55.3) | 0.030 |
Diabetes mellitus, n (%) | 124(22.5) | 168(27.1) | 0.065 |
Family history, n (%) | 90(16.3) | 134(21.5) | 0.020 |
BMI, kg/m2 | 24.80 ± 3.43 | 25.16 ± 3.10 | 0.063 |
SBP, mmHg | 126.82 ± 19.60 | 124.74 ± 21.57 | 0.084 |
DBP, mmHg | 79.28 ± 13.00 | 77.98 ± 13.56 | 0.096 |
Heart rate, bmp | 73.63 ± 10.14 | 74.83 ± 15.04 | 0.107 |
LVEF, % | 56.60 ± 8.88 | 55.25 ± 11.04 | 0.021 |
Creatinine, mg/dl | 79.09 ± 16.48 | 81.42 ± 22.06 | 0.042 |
FBG, mmol/l | 6.42 ± 1.45 | 6.72 ± 1.91 | 0.002 |
CK, U/l(IQR) | 73.65(58.88) | 91.50(80.20) |  < 0.001 |
CK-MB, U/l(IQR) | 11.60(5.58) | 13.50(10.50) |  < 0.001 |
FIB, g/l | 3.05 ± 1.15 | 3.72 ± 1.14 |  < 0.001 |
D-Dimer, mg/l(IQR) | 0.56(0.84) | 0.85(0.70) |  < 0.001 |
FDP, mg/l | 3.04 ± 1.15 | 3.72 ± 1.72 |  < 0.001 |
CRP, μg/ml | 2.75 ± 0.92 | 6.47 ± 2.94 |  < 0.001 |
BNP, ng/l(IQR) | 124.99(193.56) | 418.87(961.20) |  < 0.001 |
TC, mmol/l | 3.82 ± 0.77 | 4.01 ± 1.07 |  < 0.001 |
TG, mmol/l | 1.87 ± 0.86 | 1.93 ± 0.80 | 0.282 |
HDLC, mmol/l | 1.01 ± 0.16 | 0.99 ± 0.23 | 0.030 |
LDLC, mmol/l | 2.24 ± 0.77 | 2.38 ± 0.91 | 0.004 |
ApoA1, g/l | 1.01 ± 0.20 | 1.02 ± 0.20 | 0.425 |
ApoB, g/l | 0.76 ± 0.24 | 0.79 ± 0.24 | 0.113 |
ApoE, g/l | 35.89 ± 12.57 | 36.85 ± 14.40 | 0.230 |
Lpa, mg/dl | 196.32 ± 69.37 | 207.00 ± 99.72 | 0.032 |
Hb, g/l | 136.25 ± 16.81 | 138.27 ± 17.39 | 0.044 |
WBC, 109 /l | 6.01 ± 2.47 | 9.00 ± 4.43 |  < 0.001 |
ACEI, % | 308(55.8) | 364(58.8) | 0.299 |
β-blocker, % | 430(77.9) | 509(82.2) | 0.063 |
Statin, % | 476(86.2) | 555(89.7) | 0.071 |
Aspirin, % | 519(94.0) | 595(96.1) | 0.095 |
CCB, % | 153(27.7) | 407(65.8) |  < 0.001 |